This Article Figures Only Free Full Text Free Free Full Text (Free PDF) Free An erratum has been published Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Teng, Y.-T.A. Search for Related Content PubMed PubMed Citation Articles by Teng, Y.-T.A. Social Bookmarking                         What's this?

Protective and Destructive Immunity in the Periodontium: Part 2—T-cell-mediated Immunity in the Periodontium

Lab. of Molecular Microbial Immunity, Eastman Department of Dentistry, Eastman Dental Center, Box-683, 625 Elmwood Ave., and Centre for Oral Biology, Dept. of Microbiology and Immunology, School of Medicine and Dentistry, The University of Rochester Medical Center, Rochester, NY 14620, USA; andy_teng{at}urmc.rochester.edu

Based on the results of recent research in the field and Part 1 of this article (in this issue), the present paper will discuss the protective and destructive aspects of the T-cell-mediated adaptive immunity associated with the bacterial virulent factors or antigenic determinants during periodontal pathogenesis. Attention will be focused on: (i) osteoimmunology and periodontal disease; (ii) some molecular techniques developed and applied to identify critical microbial virulence factors or antigens associated with host immunity (with Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis as the model species); and (iii) summarizing the identified virulence factors/antigens associated with periodontal immunity. Thus, further understanding of the molecular mechanisms of the host’s T-cell-mediated immune responses and the critical microbial antigens related to disease pathogenesis will facilitate the development of novel therapeutics or protocols for future periodontal treatments. Abbreviations used in the paper are as follows: A. actinomycetemcomitans (Aa), Actinobacillus actinomycetemcomitans; Ab, antibody; DC, dendritic cells; mAb, monoclonal antibody; pAb, polyclonal antibody; OC, osteoclast; PAMP, pathogen-associated molecular patterns; P. gingivalis (Pg), Porphyromonas gingivalis; RANK, receptor activator of NF-B; RANKL, receptor activator of NF-B ligand; OPG, osteoprotegerin; TCR, T-cell-receptors; TLR, Toll-like receptors.

Key Words: Actinobacillus actinomycetemcomitans (Aa) • T-cell-mediated immunity • RANKL and cytokine interactions network (RACIN) • osteoclastogenesis • osteoimmunology

Journal of Dental Research, Vol. 85, No. 3, 209-219 (2006)
DOI: 10.1177/154405910608500302


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				X. Zhang, M. Alnaeeli, B. Singh, and Y.-T. A. Teng Involvement of SOCS3 in Regulation of CD11c+ Dendritic Cell-Derived Osteoclastogenesis and Severe Alveolar Bone Loss Infect. Immun., May 1, 2009; 77(5): 2000 - 2009. [Abstract] [Full Text] [PDF]

				J. R. Kiesel, Z. S. Buchwald, and R. Aurora Cross-Presentation by Osteoclasts Induces FoxP3 in CD8+ T Cells J. Immunol., May 1, 2009; 182(9): 5477 - 5487. [Abstract] [Full Text] [PDF]

				N. Bostanci, G. Emingil, B. Afacan, B. Han, T. Ilgenli, G. Atilla, F.J. Hughes, and G.N. Belibasakis Tumor Necrosis Factor-{alpha}-converting Enzyme (TACE) Levels in Periodontal Diseases Journal of Dental Research, March 1, 2008; 87(3): 273 - 277. [Abstract] [Full Text] [PDF]

				X. Zhang and Y.-T. A. Teng Interleukin-10 Inhibits Gram-Negative-Microbe-Specific Human Receptor Activator of NF-{kappa}B Ligand-Positive CD4+-Th1-Cell- Associated Alveolar Bone Loss In Vivo Infect. Immun., August 1, 2006; 74(8): 4927 - 4931. [Abstract] [Full Text] [PDF]